Neila Benabadji is currently the VP and Head of Regulatory Affairs Europe at Cytokinetics, a position held since 2024. Previously, Neila worked at Bayer HealthCare as a Regulatory Affairs Specialist from 2008 to 2010, and at Pfizer in worldwide regulatory strategy from 2007 to 2008. Neila has also held various roles at Novartis, including Global Program Regulatory Director for secukinumab in both rheumatology and dermatology, and at Reata Pharmaceuticals as Associate Vice President of Global Regulatory Affairs. Neila earned a Doctor of Pharmacy (PharmD) from Pharmaceutical University-Reims and holds a Master's degree in Drug Development and International Registration from Université Paris Sud.